netFormulary Leeds Formulary NHS
Leeds Teaching Hospitals NHS Trust
Leeds and York Partnership NHS Foundation Trust
Leeds Community Healthcare NHS Trust
NHS Leeds CCG
 
 Introduction

Welcome to the Leeds Medicines Formulary

Useful Links

meandmymedicines

 Adult BNF
 Paediatric BNF
BNF Apps (iOS and Android) 

Further Medicines Management Resources

NHS Leeds Traffic Light List

Antimicrobial guidelines

Compliance with NICE technology appraisals

otcmedicines

 

 

News Feed

MHRA: Drug Safety Update (June 2019) Oral retinoid medicines▼: revised and simplified pregnancy prevention educational materials for healthcare professionals and women


MHRA: Drug Safety Update (June 2019) Lartruvo▼ (olaratumab): withdrawal of the EU marketing authorisation due to lack of efficacy


MHRA: Drug Safety Update (June 2019) GLP-1 receptor agonists: reports of diabetic ketoacidosis when concomitant insulin was rapidly reduced or discontinued


MHRA: Drug Safety Update (June 2019) Direct-acting oral anticoagulants (DOACs): increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome


MHRA: Drug Safety Update (May 19) Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy


MHRA: Drug Safety Update (May 19) Tofacitinib (Xeljanz▼): restriction of 10 mg twice-daily dose in patients at high risk of pulmonary embolism while safety review is ongoing


>>> more news

Leeds Secondary Care Links

LTHT Injectable Medicines Guides (Medusa)
Adult IV monographs
Paediatric IV monographs     .

 


NetFormulary
   Last updated: 17/07/2019 13:57:11